Navigation Links
Developer Of Vaccine For Cancer Granted A Prestigious Fellowship

Researcher, Professor Ian Frazer of the University of Queensland (UQ), has been awarded the Smart State Premier's Fellowship. The prestigious Fellowship comes on top// of his recent Australian of the Year award for his work in developing a vaccine for cervical cancer. Under the Smart State Premier's Fellowship, Professor Ian Frazer will get $250,000 a year for the next five years for his UQ Centre for Immunology and Cancer Research at Brisbane’s Princess Alexandra Hospital. Professor Frazer said the money would help further the development of therapeutic vaccines.

The Smart State Premier's Fellowships provide funding to entice experienced and distinguished researchers of national and international prominence to lead research teams in Queensland universities, research institutes, government agencies or industry research facilities.

Prof Frazer said on ABC Radio, that though The Australian of the Year is a great honour but it is very much an honorary title, and now this fellowship will help him to build up his team and get new initiatives going in the way of research, specifically towards the vaccines that they have been striving to get for the last few years.

Deputy Premier, Treasurer and Minister for State Development, Trade and Innovation Anna Bligh announced the funding today who was in Chicago as part of a trade mission. Stating that the Professor Frazer has put Queensland on the map with his ground breaking scientific achievements. She said that the fellowship money would help Prof Frazer translate the success of the cervical cancer vaccine to other cancers and infections.

The professor has been researching the cause of cervical cancer for the past 20 years and has proven the link between cervical cancers and the papilloma virus. He has also developed the world's first vaccine for cervical cancer. This cancer alone kills 270,000 women each year
'"/>




Page: 1

Related medicine news :

1. Male Contraception: Discovery Stirring Interest Among Scientists, Drug Developers
2. Vaccine to quit smoking?
3. First Vaccine Designed for Africa Cleared for Testing in Humans
4. Vaccine for Alzheimer’s diseas
5. Health Officials Recommend Flu Vaccine
6. Smallpox Vaccine May Help Fight Cervical Cancer
7. Panacea Biotech To Market Anthrax Vaccine
8. New Prostate Cancer Vaccine Shows Promise
9. Drug Firm Offers to Donate Smallpox Vaccine
10. Vaccine guards against shingles
11. Vaccine for septic conditions
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... PASADENA, CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. ... he would lash out at his family verbally and physically. , “When something upset him, ... table, he would use it. He would throw rocks at my other children and say ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 26, 2016 One of Australia,s ... announced the formation of a new biotechnology company, Noxopharm Limited [ABN ... in an IPO and to list on the ASX. ... NOX66, ready to enter a Phase 1 clinical study later this ... to address one of the biggest problems facing cancer patients - ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: